• Something wrong with this record ?

The management of cancer patients : separate research experiences with gemcitabine HC1 and DAB389IL-2 fusion protein : based on scientific proceedings of an Eli Lilly and Company satellite symposium at the 8th European conference on Clinical Oncology and Cancer Nursing in Paris : 29 October - 2 November 1995

guest editor P.E. Postmus

Published
Oxford : Pergamon Press, 1997
Series
European journal of cancer, ISSN 0959-8049 Supplement Vol. 33. 1
Pagination
S35 s. : il. ; 32 cm

Language English Country Great Britain

Document type Congress, Collected Work

Persistent link   https://www.medvik.cz/link/MED00044603
Supplement Parent

European journal of cancer. ISSN 0959-8049

Bibliography, etc.

Skrytá bibl.

Owner Details Services
NLK NLK 1997 Shelf no. B 1390/33-S.1-1997 [1]
Volume Location Shelf no. Status Order
000      
02011nam 2200469 a 4500
001      
MED00044603
003      
CZ-PrNML
005      
20141219132510.0
008      
980715s1997 xxk eng||
009      
BK
020    __
$q (Brož.)
040    __
$a ABA008 $b cze $e AACR2
041    0_
$a eng
044    __
$a xxk $c GB
072    _7
$x Lékařské vědy. Lékařství $a 61 $2 konspekt $7 sk136310
080    __
$a 616-006 $2 h
080    __
$a 615 $2 h
111    2_
$a European Conference on Clinical Oncology and Cancer Nursing $n (8th : $d 1995 : $c conference) $e Paris
245    14
$a The management of cancer patients : $b separate research experiences with gemcitabine HC1 and DAB389IL-2 fusion protein : based on scientific proceedings of an Eli Lilly and Company satellite symposium at the 8th European conference on Clinical Oncology and Cancer Nursing in Paris : 29 October - 2 November 1995 / $c guest editor P.E. Postmus
260    __
$a Oxford : $b Pergamon Press, $c 1997
300    __
$a S35 s. : $b il. ; $c 32 cm
490    1_
$a European journal of cancer, $x 0959-8049 ; $v Supplement Vol. 33. 1
504    __
$a Skrytá bibl.
650    07
$a nádory $x farmakoterapie $2 czmesh $7 D009369
650    07
$a deoxycytidin $x antagonisté a inhibitory $2 czmesh $7 D003841
650    07
$a receptory interleukinů $x antagonisté a inhibitory $2 czmesh $7 D018123
650    07
$a interleukin-2 $x antagonisté a inhibitory $2 czmesh $7 D007376
650    07
$a rekombinantní fúzní proteiny $2 czmesh $7 D011993
650    07
$a klinické zkoušky jako téma $2 czmesh $7 D002986
650    07
$a onkologie $2 mednas $7 nlk20040148136
650    07
$a farmacie a farmakologie $2 mednas $7 nlk20040147252
655    _7
$a kongresy $2 czmesh $7 D016423
655    _7
$a sborníky $2 czmesh $7 D020470
700    1_
$a Postmus, P.E. $4 edt $7 _gn020033147
772    0_
$w MED00009626 $t European journal of cancer $x 0959-8049
830    _0
$a European journal of cancer, $x 0959-8049
910    __
$a ABA008 $b B 1390/33-S.1-1997 $y x
990    __
$a 19980715 $b ABA008
991    __
$a 20050814 $b ABA008
BAS    __
$a NML $a 02 $a 12 $a 30
LKV    __
$a MED00009626 $b 1997 33 1
LZP    __
$b 51